Molécules prometteuses dans le traitement du cancer du sein - Promising molecules for breast cancer therapy (20 08)

Molécules prometteuses dans le traitement du cancer du sein -
Promising molecules for breast cancer therapy (2008)


denosumab, odanacatib, anastrozole, letrozole, exemestane,
bevacizumab, brivanib, sunitinib, ramucirumab, cetuximab, CP-751871,
IMC-A12, MK-0646, OSI-906, olaparib, BSI-201, ABT-888, carboplatin,
dasatinib, saracatinib, trastuzumab, trastuzumab-DM1, pertuzumab,
lapatinib, neratinib, BIBW-2992, tanespimycin, AVX-701, CDX-1307,
OCPM, everolimus, deforolimus, temsirolimus, GDC-0941, XL-765,
capecitabine, vinflunine, abraxane, ixabepilone, patupilone,
zoledronic acid, ibandronate, clodronate, alendronate, risedronate


InTextoResearch, Baelen, Wallonie (Wallonia), Belgique (Belgium) &
Agence Wallonne d’Information Scientifique (AWIS) (Marc Lacroix,
scimedweb@mail.com)